http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09508125-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate | 1995-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1997-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H09508125-A |
titleOfInvention | Method and composition for the treatment of androgen dependent diseases using optically pure R-(-)-casodex |
abstract | (57) [Summary]nOptical Pure R for Treating Androgen-Dependent Prostate Cancer, While Substantially Reducing the Synergistic Disadvantages of the Counter-effects Related to Central Antiandrogen Activity of Racemic Mixtures of Casodex -(-)-Casodex utilization methods and compositions are disclosed. R-(-)-Casodex is a peripherally selective anti-androgen and is therefore useful in the treatment of other male hormone-dependent conditions or conditions induced by elevated androgen levels. These conditions include benign prostatic hyperplasia or thickening, acne, and hirsutism. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003512351-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003513955-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4778178-B2 |
priorityDate | 1994-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.